{"id":"https://openalex.org/W2931979088","doi":null,"title":"Entinostat Plus Pembrolizumab Shows Promise in Previously Treated Melanoma","display_name":"Entinostat Plus Pembrolizumab Shows Promise in Previously Treated Melanoma","publication_year":2019,"publication_date":"2019-04-04","ids":{"openalex":"https://openalex.org/W2931979088","mag":"2931979088"},"language":"en","primary_location":{"id":"mag:2931979088","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/aacr-street-team/entinostat-plus-pembrolizumab-shows-promise-previously-treated-melanoma","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ryan J. Sullivan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5344-6645","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5008479799"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.03071171,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.021700000390410423,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/entinostat","display_name":"entinostat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9610000252723694},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5550000071525574},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.5419999957084656},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.7149999737739563},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8579999804496765}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8571352958679199},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5304878354072571},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.42169347405433655},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3790813684463501},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2633534371852875},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2385796308517456},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1970752477645874},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16842016577720642}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2931979088","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/aacr-street-team/entinostat-plus-pembrolizumab-shows-promise-previously-treated-melanoma","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2955958085","https://openalex.org/W2807611908","https://openalex.org/W4214502737","https://openalex.org/W7162528166","https://openalex.org/W2886811182","https://openalex.org/W2890660292","https://openalex.org/W2945329325","https://openalex.org/W2892111420","https://openalex.org/W4206340874","https://openalex.org/W2890578922"],"abstract_inverted_index":{"Cancer":[0],"Network":[1],"spoke":[2],"with":[3,21],"Ryan":[4],"J.":[5],"Sullivan,":[6],"MD,":[7],"about":[8],"the":[9],"efficacy":[10],"and":[11],"safety":[12],"of":[13],"entinostat":[14],"plus":[15],"pembrolizumab":[16],"in":[17],"patients":[18],"previously":[19],"treated":[20],"immunotherapy.":[22]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-04-11T00:00:00"}